Enhancing study success with advanced clinical research technologies and expert solutions for Rheumatoid Arthritis trials.
Rheumatoid Arthritis
Trial Solutions
Effective solutions for advancing Rheumatoid Arthritis research
Signant Health can apply decades of clinical science and medicine experience, as well as innovative clinical trial technologies within our SmartSignals™ platform, to help researchers detect safety and efficacy signals while increasing the quality and reliability of data generated.
Ongoing research is critical in the continued effort to identify therapies and treatments for Rheumatoid Arthritis patients whose lives are significantly impacted by the effects of this disease. Signant Health can apply decades of direct clinical experience, deep therapeutic-area expertise, and innovative clinical trial technologies within our Signant SmartSignals platform to help researchers detect signal while increasing the quality and reliability of endpoint data.
Why Signant Health
- A Better Way to Collect RA Outcome Assessments Data
- Enable Accurate ClinROs
- Maximize IP Supply Chain Efficiency
- Combine Solutions for an End-to-End Digitized Study
-
A Better Way to Collect RA Outcome Assessments Data
A Better Way to Collect RA Outcome Assessments Data
Patient-reported outcome measures are an increasingly important factor in RA study endpoints. Maximize the reliability and accuracy of data by leveraging our eCOA platform, which simplifies participation for RA patients and reduces burdens for sites and study teams. -
Enable Accurate ClinROs
Enable Accurate ClinROs
Clinician-reported outcome assessments provide valuable insight into disease activity and its impact on function and quality of life. Ensure accuracy and reliability with Signant’s Electronic Clinician Ratings, a utility within our eCOA platform. -
Maximize IP Supply Chain Efficiency
Maximize IP Supply Chain Efficiency
Signant’s RTSM solution can be implemented rapidly in just one to four weeks for RA studies and utilizes a unique algorithm to dynamically optimize lot usage. We focus on reducing waste, reconciliation/returns efforts, and the number of shipments required to ensure compounds for these studies do not go to waste through overages or expiration. -
Combine Solutions for an End-to-End Digitized Study
Combine Solutions for an End-to-End Digitized Study
Each solution and service within our SmartSignals evidence generation platform can be used independently for site-based or remote studies, but when combined, they create a digital ecosystem for creating and managing accurate, regulatory-compliant clinical data.
Comprehensive Rheumatoid Arthritis experience
STUDIES
PATIENTS
COUNTRIES
SITES
Explore our Rheumatoid Arthritis trial resources
eClinical solutions for Rheumatoid Arthritis trials
Ready to learn more?
Discover how Signant can support your current or upcoming rheumatoid arthritis trials.